SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-20-017243
Filing Date
2020-09-03
Accepted
2020-09-03 17:05:58
Documents
68

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 2395963
2 ex5-1.htm EX-5.1 17587
3 ex23-1.htm EX-23.1 3188
4 ex5-1_001.jpg GRAPHIC 5533
5 ex5-1_002.jpg GRAPHIC 2757
  Complete submission text file 0001493152-20-017243.txt   6500435

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE lixt-20200630.xml EX-101.INS 883503
7 XBRL SCHEMA FILE lixt-20200630.xsd EX-101.SCH 62181
8 XBRL CALCULATION FILE lixt-20200630_cal.xml EX-101.CAL 42209
9 XBRL DEFINITION FILE lixt-20200630_def.xml EX-101.DEF 279384
10 XBRL LABEL FILE lixt-20200630_lab.xml EX-101.LAB 346461
11 XBRL PRESENTATION FILE lixt-20200630_pre.xml EX-101.PRE 346735
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-248588 | Film No.: 201159887
SIC: 2834 Pharmaceutical Preparations